Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine M Tangen

Showing results (1-10 of 217) with videos related to

Pageof 22
Sort By:
Nature Clinical Practice. Urology|June 10, 2006
Does prostate volume affect accurate grading of prostate biopsies?Ian M Thompson, Catherine M Tangen
The New England Journal of Medicine|July 20, 2012
Prostate cancer--uncertainty and a way forwardIan M Thompson, Catherine M Tangen
Lancet (London, England)|August 11, 2014
Prostate cancer screening comes of ageIan M Thompson, Catherine M Tangen
Nature Reviews. Urology|June 6, 2009
Clinical trials: 'clinical integration': laudable, but challengingE David Crawford, Catherine M Tangen
JAMA Internal Medicine|October 8, 2019
5α-Reductase Inhibitor Use in Patients With Prostate CancerIan M Thompson, Catherine M Tangen, Barnett Kramer
Journal of the National Cancer Institute|August 21, 2010
Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigmaIan M Thompson, Donna P Ankerst, Catherine M Tangen
International Journal of Epidemiology|April 25, 2007
Commentary: the ubiquity of prostate cancer: echoes of the past, implications for the present: "what has been will be again, what has been done will be done again; there is nothing new under the sun." ECCLESIASTES 1:9Ian M Thompson, M Scott Lucia, Catherine M Tangen
Journal of the National Cancer Institute|October 30, 2008
Prostate-specific antigen: a misused and maligned prostate cancer biomarkerIan M Thompson, Catherine M Tangen, Alan R Kristal
BJU International|March 21, 2008
The Prostate Cancer Prevention Trial and the future of chemopreventionIan M Thompson, Catherine M Tangen, M Scott Lucia
Seminars in Oncology|October 5, 2015
Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology ProgramLori M Minasian, Catherine M Tangen, D Lawrence Wickerham
Pageof 22

Showing results (1-10 of 217) with videos related to

Sort By:
Pageof 22
Nature Clinical Practice. Urology|June 10, 2006
Does prostate volume affect accurate grading of prostate biopsies?Ian M Thompson, Catherine M Tangen
The New England Journal of Medicine|July 20, 2012
Prostate cancer--uncertainty and a way forwardIan M Thompson, Catherine M Tangen
Lancet (London, England)|August 11, 2014
Prostate cancer screening comes of ageIan M Thompson, Catherine M Tangen
Nature Reviews. Urology|June 6, 2009
Clinical trials: 'clinical integration': laudable, but challengingE David Crawford, Catherine M Tangen
JAMA Internal Medicine|October 8, 2019
5α-Reductase Inhibitor Use in Patients With Prostate CancerIan M Thompson, Catherine M Tangen, Barnett Kramer
Journal of the National Cancer Institute|August 21, 2010
Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigmaIan M Thompson, Donna P Ankerst, Catherine M Tangen
International Journal of Epidemiology|April 25, 2007
Commentary: the ubiquity of prostate cancer: echoes of the past, implications for the present: "what has been will be again, what has been done will be done again; there is nothing new under the sun." ECCLESIASTES 1:9Ian M Thompson, M Scott Lucia, Catherine M Tangen
Journal of the National Cancer Institute|October 30, 2008
Prostate-specific antigen: a misused and maligned prostate cancer biomarkerIan M Thompson, Catherine M Tangen, Alan R Kristal
BJU International|March 21, 2008
The Prostate Cancer Prevention Trial and the future of chemopreventionIan M Thompson, Catherine M Tangen, M Scott Lucia
Seminars in Oncology|October 5, 2015
Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology ProgramLori M Minasian, Catherine M Tangen, D Lawrence Wickerham
Pageof 22